Quantitative proteome profiling of C. burnetii under tetracycline stress conditions

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Vranakis, Iosif ^a   de Bock, Pieter Jan ^b,c   Papadioti, Anastasia ^a   Tselentis, Yannis ^a   Gevaert, Kris ^b,c   Tsiotis, Georgios ^a   Psaroulaki, Anna ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; TETRACYCLINE; BACTERIAL PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CHEMICAL STRESS; CHROMATOGRAPHY; CONTROLLED STUDY; COXIELLA BURNETII; ENZYME REGULATION; MASS SPECTROMETRY; NONHUMAN; PLASTICITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; Q FEVER; QUANTITATIVE ANALYSIS; DOWN REGULATION; DRUG EFFECT; HUMAN; METABOLISM; MICROBIOLOGY; PHYSIOLOGICAL STRESS; PROTEIN MICROARRAY; UPREGULATION;

COXIELLA BURNETII;

BACTERIAL PROTEINS; COXIELLA BURNETII; DOWN-REGULATION; DRUG RESISTANCE, BACTERIAL; HUMANS; PROTEIN ARRAY ANALYSIS; PROTEOME; PROTEOMICS; Q FEVER; STRESS, PHYSIOLOGICAL; TETRACYCLINE; UP-REGULATION;

EID: 84858397476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033599     Document Type: Article

References (63)

1. Omsland A, Beare PA, Hill J, Cockrell DC, Howe D, et al. (2011) Isolation from Animal Tissue and Genetic Transformation of Coxiella burnetii Are Facilitated by an Improved Axenic Growth Medium. Appl Environ Microbiol 77: 3720-3725.
2. Omsland A, Cockrell DC, Howe D, Fischer ER, Virtaneva K, et al. (2009) Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc Natl Acad Sci U S A 106: 4430-4434.
3. Derrick EH, (1937) Q" fever, a new fever entity: clinical features, diagnosis and laboratory investigation. Medical Journal of Australia 2: 281-299.
4. Tissot-Dupont H, Vaillant V, Rey S, Raoult D, (2007) Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis 44: 232-237.
5. Gami AS, Antonios VS, Thompson RL, Chaliki HP, Ammash NM, (2004) Q fever endocarditis in the United States. Mayo Clin Proc 79: 253-257.
6. Angelakis E, Raoult D, (2010) Q Fever. Vet Microbiol 140: 297-309.
7. Joshi N, Miller DQ, (1997) Doxycycline revisited. Arch Intern Med 157: 1421-1428.
8. Maurin M, Raoult D, (1999) Q fever. Clin Microbiol Rev 12: 518-553.
9. Rolain JM, Mallet MN, Raoult D, (2003) Correlation between serum doxycycline concentrations and serologic evolution in patients with Coxiella burnetii endocarditis. J Infect Dis 188: 1322-1325.
10. Rolain JM, Lambert F, Raoult D, (2005) Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline. Ann N Y Acad Sci 1063: 252-256.
11. Turck WP, Howitt G, Turnberg LA, Fox H, Longson M, et al. (1976) Chronic Q fever. Q J Med 45: 193-217.
12. Chopra I, Hawkey PM, Hinton M, (1992) Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother 29: 245-277.
13. Brodersen DE, Clemons WM Jr, Carter AP, Morgan-Warren RJ, Wimberly BT, et al. (2000) The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 103: 1143-1154.
14. Thaker M, Spanogiannopoulos P, Wright GD, (2010) The tetracycline resistome. Cell Mol Life Sci 67: 419-431.
15. Beare PA, Unsworth N, Andoh M, Voth DE, Omsland A, et al. (2009) Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella. Infect Immun 77: 642-656.
16. Gevaert K, Van Damme J, Goethals M, Thomas GR, Hoorelbeke B, et al. (2002) Chromatographic isolation of methionine-containing peptides for gel-free proteome analysis: identification of more than 800 Escherichia coli proteins. Mol Cell Proteomics 1: 896-903.
17. Samoilis G, Psaroulaki A, Vougas K, Tselentis Y, Tsiotis G, (2007) Analysis of whole cell lysate from the intercellular bacterium Coxiella burnetii using two gel-based protein separation techniques. J Proteome Res 6: 3032-3041.
18. Colaert N, Helsens K, Impens F, Vandekerckhove J, Gevaert K, (2010) Rover: a tool to visualize and validate quantitative proteomics data from different sources. Proteomics 10: 1226-1229.
19. Paetzel M, Dalbey RE, Strynadka NC, (1998) Crystal structure of a bacterial signal peptidase in complex with a beta-lactam inhibitor. Nature 396: 186-190.
20. Tuteja R, (2005) Type I signal peptidase: an overview. Arch Biochem Biophys 441: 107-111.
21. Dalbey RE, Wickner W, (1985) Leader peptidase catalyzes the release of exported proteins from the outer surface of the Escherichia coli plasma membrane. J Biol Chem 260: 15925-15931.
22. Date T, (1983) Demonstration by a novel genetic technique that leader peptidase is an essential enzyme of Escherichia coli. J Bacteriol 154: 76-83.
23. Dalbey RE, Lively MO, Bron S, van Dijl JM, (1997) The chemistry and enzymology of the type I signal peptidases. Protein Sci 6: 1129-1138.
24. Date T, Wickner W, (1981) Isolation of the Escherichia coli leader peptidase gene and effects of leader peptidase overproduction in vivo. Proc Natl Acad Sci U S A 78: 6106-6110.
25. Black MT, Bruton G, (1998) Inhibitors of bacterial signal peptidases. Curr Pharm Des 4: 133-154.
26. Samland AK, Sprenger GA, (2009) Transaldolase: from biochemistry to human disease. Int J Biochem Cell Biol 41: 1482-1494.
27. Vinnikov AI, Babenko Iu S, (1989) [Features of glycolysis and pentose phosphate pathway in novobiocin sensitive and novobiocin resistant staphylococci]. Antibiot Khimioter 34: 34-38.
28. Boshoff HI, Reed MB, Barry CE 3rd, Mizrahi V, (2003) DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 113: 183-193.
29. Hu X, Norris AL, Baudry J, Serpersu EH, (2011) Coenzyme A Binding to the Aminoglycoside Acetyltransferase (3)-IIIb Increases Conformational Sampling of Antibiotic Binding Site. Biochemistry 50: 10559-10565.
30. Heinzen RA, Howe D, Mallavia LP, Rockey DD, Hackstadt T, (1996) Developmentally regulated synthesis of an unusually small, basic peptide by Coxiella burnetii. Mol Microbiol 22: 9-19.
31. Vranakis I, De Bock PJ, Papadioti A, Tselentis Y, Gevaert K, et al. (2011) Identification of potentially involved proteins in levofloxacin resistance mechanisms in Coxiella burnetii. J Proteome Res 10: 756-762.
32. Vranakis I, De Bock PJ, Papadioti A, Samoilis G, Tselentis Y, et al. (2011) Unraveling Persistent Host Cell Infection with Coxiella burnetii by Quantitative Proteomics. J Proteome Res 10: 4241-4251.
33. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ, (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797-810.
34. Yeom J, Imlay JA, Park W, (2010) Iron homeostasis affects antibiotic-mediated cell death in Pseudomonas species. J Biol Chem 285: 22689-22695.
35. Stojiljkovic I, Cobeljic M, Hantke K, (1993) Escherichia coli K-12 ferrous iron uptake mutants are impaired in their ability to colonize the mouse intestine. FEMS Microbiol Lett 108: 111-115.
36. Chen L, Xiong S, She H, Lin SW, Wang J, et al. (2007) Iron causes interactions of TAK1, p21ras, and phosphatidylinositol 3-kinase in caveolae to activate IkappaB kinase in hepatic macrophages. J Biol Chem 282: 5582-5588.
37. Xiong S, She H, Takeuchi H, Han B, Engelhardt JF, et al. (2003) Signaling role of intracellular iron in NF-kappaB activation. J Biol Chem 278: 17646-17654.
38. Agafonov DE, Kolb VA, Spirin AS, (2001) A novel stress-response protein that binds at the ribosomal subunit interface and arrests translation. Cold Spring Harb Symp Quant Biol 66: 509-514.
39. Maki Y, Yoshida H, Wada A, (2000) Two proteins, YfiA and YhbH, associated with resting ribosomes in stationary phase Escherichia coli. Genes Cells 5: 965-974.
40. Agafonov DE, Kolb VA, Spirin AS, (2001) Ribosome-associated protein that inhibits translation at the aminoacyl-tRNA binding stage. EMBO Rep 2: 399-402.
41. Agafonov DE, Kolb VA, Nazimov IV, Spirin AS, (1999) A protein residing at the subunit interface of the bacterial ribosome. Proc Natl Acad Sci U S A 96: 12345-12349.
42. Connell SR, Tracz DM, Nierhaus KH, Taylor DE, (2003) Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob Agents Chemother 47: 3675-3681.
43. Burdett V, (1996) Tet(M)-promoted release of tetracycline from ribosomes is GTP dependent. J Bacteriol 178: 3246-3251.
44. Taylor DE, Chau A, (1996) Tetracycline resistance mediated by ribosomal protection. Antimicrob Agents Chemother 40: 1-5.
45. Shoji S, Janssen BD, Hayes CS, Fredrick K, (2010) Translation factor LepA contributes to tellurite resistance in Escherichia coli but plays no apparent role in the fidelity of protein synthesis. Biochimie 92: 157-163.
46. Paulsen IT, Brown MH, Skurray RA, (1996) Proton-dependent multidrug efflux systems. Microbiol Rev 60: 575-608.
47. Tamura N, Konishi S, Yamaguchi A, (2003) Mechanisms of drug/H+ antiport: complete cysteine-scanning mutagenesis and the protein engineering approach. Curr Opin Chem Biol 7: 570-579.
48. Linares JF, Gustafsson I, Baquero F, Martinez JL, (2006) Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci U S A 103: 19484-19489.
49. Yim G, Wang HH, Davies J, (2006) The truth about antibiotics. Int J Med Microbiol 296: 163-170.
50. Yim G, Wang HH, Davies J, (2007) Antibiotics as signalling molecules. Philos Trans R Soc Lond B Biol Sci 362: 1195-1200.
51. Fajardo A, Martinez JL, (2008) Antibiotics as signals that trigger specific bacterial responses. Curr Opin Microbiol 11: 161-167.
52. Yergeau E, Lawrence JR, Waiser MJ, Korber DR, Greer CW, (2010) Metatranscriptomic analysis of the response of river biofilms to pharmaceutical products, using anonymous DNA microarrays. Appl Environ Microbiol 76: 5432-5439.
53. Martinez JL, Fajardo A, Garmendia L, Hernandez A, Linares JF, et al. (2009) A global view of antibiotic resistance. FEMS Microbiol Rev 33: 44-65.
54. Martinez JL, Sanchez MB, Martinez-Solano L, Hernandez A, Garmendia L, et al. (2009) Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev 33: 430-449.
55. Martinez JL, (2008) Antibiotics and antibiotic resistance genes in natural environments. Science 321: 365-367.
56. Aminov RI, (2009) The role of antibiotics and antibiotic resistance in nature. Environ Microbiol 11: 2970-2988.
57. Fajardo A, Linares JF, Martinez JL, (2009) Towards an ecological approach to antibiotics and antibiotic resistance genes. Clin Microbiol Infect 15 (Suppl 1): 14-16.
58. Breidenstein EB, Khaira BK, Wiegand I, Overhage J, Hancock RE, (2008) Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Chemother 52: 4486-4491.
59. Tamae C, Liu A, Kim K, Sitz D, Hong J, et al. (2008) Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli. J Bacteriol 190: 5981-5988.
60. Dotsch A, Becker T, Pommerenke C, Magnowska Z, Jansch L, et al. (2009) Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53: 2522-2531.
61. Gimenez DF, (1964) Staining Rickettsiae in Yolk-Sac Cultures. Stain Technol 39: 135-140.
62. Maurin M, Raoult D, (1997) Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii. J Antimicrob Chemother 39: 725-730.
63. Ghesquiere B, Colaert N, Helsens K, Dejager L, Vanhaute C, et al. (2009) In vitro and in vivo protein-bound tyrosine nitration characterized by diagonal chromatography. Mol Cell Proteomics 8: 2642-2652.